Vivriti Capital / Hari & Co. Bonds Explained: NCD Structure, Rating & Key Risks

Quick Overview
• Issuer: Vivriti Capital Limited (VCL), an NBFC in the Vivriti group. It was called Hari & Company Investments Madras Private Limited until it was renamed on June 13, 2026.
• Why the name changed: the NBFC business of the earlier Vivriti Capital Limited moved into this company on April 1, 2026, and it then took the Vivriti Capital name.
• Ratings: [ICRA]A+ (Stable), reaffirmed on June 23, 2026; CARE A+; Stable, assigned on April 17, 2026 (no later CARE action found as of November 13, 2026 ; Crisil A+ (assigned April 10, 2026), with the outlook revised to Positive on July 16, 2026 and the rating reaffirmed at Crisil A+/Positive on September 24, 2026.
• Rated NCD amounts: ₹608 crore (ICRA, June 2026) and ₹1,150 crore (CARE, April 2026). These are separate disclosures, not one issue, so do not add them.
• Size: assets under management (AUM) of ₹11,851 crore as of March 2026, up 27% from a year earlier, and ₹11,395 crore as of June 30, 2026 (Crisil, September 24, 2026).
• FY2026 results: profit after tax of ₹264 crore, gross Stage 3 loans of 2.2% and capital adequacy of 21.0%.
• Latest reported quarter (Q1 FY2027, ended June 30, 2026, per Crisil): profit after tax of ₹73 crore, gross Stage 3 loans of 2.2% and capital adequacy of 22.5%.
• Main risks: rising bad loans, unsecured lending, dependence on co-lending partners, higher funding costs and a loan book that is still young.
• Bottom line: A+ means an adequate degree of safety, which is a mid-tier investment-grade rating. It does not guarantee repayment.
Introduction
Corporate bonds and Non-Convertible Debentures (NCDs) are debt securities that some investors consider alongside savings accounts and fixed deposits. But a higher interest rate always comes with more risk. Before buying any debt security you need to understand who the issuer is, how strong its finances are, what its credit rating means, how and when you will be repaid, and what could go wrong.
Vivriti Capital Limited (VCL) is an NBFC that lends to financial institutions, businesses and, through partnerships, retail borrowers. Until June 13, 2026 it was named Hari & Company Investments Madras Private Limited, and many bond platforms, rating reports and search results still use the old name. In April 2026 it received A+ ratings with a Stable outlook from ICRA and CARE Ratings, and an A+/Stable rating from Crisil as well. ICRA reaffirmed its rating on June 23, 2026, under the new name. Crisil revised its outlook to Positive on July 16, 2026 and reaffirmed the rating on September 24, 2026.
This guide covers the name change, the company's background, how its NCDs work, what the ratings really say, its financial performance, its funding and lending mix, the key risks, and a checklist to use before you invest.
Name Change: From Hari & Company Investments Madras to Vivriti Capital Limited
If you searched for "Hari & Co. bonds" and landed here, you are in the right place. It is the same issuer, under a new name. The change came out of a restructuring within the Vivriti group, and it has caused some confusion because two different companies have carried the name Vivriti Capital Limited.
• The earlier Vivriti Capital Limited (eVCL) was the lender promoted in 2017 that built the loan book and issued the NCDs.
• Hari & Company Investments Madras Private Limited (HCIMPL) was an older group company that Vivriti Next Limited acquired in March 2024.
• Under a composite scheme of arrangement, the NBFC business of eVCL, with its loans, borrowings and rated debt, was transferred to HCIMPL.
• HCIMPL was then renamed Vivriti Capital Limited (VCL). That is the issuer this article covers.
ICRA noted in its June 23, 2026 report that about 99% of the total assets of eVCL as of March 31, 2026 moved across, excluding small investments in Credavenue Private Limited and in the asset management business. The asset management business went to a separate group company. Vivriti Next Limited holds 100% of VCL.
What this means for you: the lending business, its track record and its debt are the same. Credit documents may still show the old name. Listing and records of some NCDs were being moved to the new name, so search by ISIN as well as by name. Debentures issued before the transfer carry ISINs in the INE01HV series, while Crisil's September 24, 2026 report lists newer NCDs, issued from July 2026, under ISINs beginning INE0P14.
| Date | What happened |
|---|---|
| September 24, 2026 | Crisil reaffirms Crisil A+/Positive and Crisil A1+ for Vivriti Capital Limited |
| July 16, 2026 | Crisil revises the outlook on Vivriti Capital Limited to Positive from Stable |
| June 23, 2026 | ICRA assigns and reaffirms [ICRA]A+ (Stable) for Vivriti Capital Limited |
| June 13, 2026 | Hari & Company Investments Madras Private Limited is renamed Vivriti Capital Limited |
| May 11, 2026 | Vivriti Funds Private Limited is renamed Vivriti Asset Management Private Limited, the group's asset management arm |
| April 10–17, 2026 | Crisil, ICRA and CARE assign A+ ratings under the old name |
| April 1, 2026 | The scheme takes effect, and the NBFC business and its listed NCDs transfer to HCIMPL |
| December 9, 2025 | The NCLT Chennai bench approves the scheme |
| March 2024 | Vivriti Next Limited acquires Hari & Company Investments Madras |
What Is Vivriti Capital Limited?
VCL is registered with the Reserve Bank of India as a non-deposit-taking, systemically important NBFC. Its lending business was promoted in June 2017 by Vineet Sukumar and Gaurav Kumar (ICRA, June 23, 2026). According to CARE Ratings' press release dated April 2, 2026, Vineet Sukumar is the managing director and has extensive financial services experience, including as CFO of a similar NBFC and CEO of that NBFC's alternative investment fund arm. Crisil's September 24, 2026 report notes that the founders have extensive experience in institutional lending and debt management.
The loan book was built over about nine years. It started with loans to financial sector entities and gradually added loans to non-financial enterprises, partnership lending and supply chain finance.
What the company does
The business lends to small and mid-sized NBFCs and companies, and serves retail borrowers through partnerships. Its products include:
• Term loans and working capital loans to financial and non-financial enterprises
• Supply chain financing for dealers and suppliers of established anchor companies
• Factoring and leasing
• Co-lending and partnership-based retail lending, mainly consumer loans, followed by small business loans and vehicle finance
As of December 31, 2025, the business served more than 300 enterprise clients and over 14 lakh retail borrowers through co-lending arrangements.
Shareholders
As of December 31, 2025, on a fully diluted basis, the business was backed by Creation Investments (51.53%), LGT group's Lightrock (23.75%), TVS Capital (3.94%) and the founders (11.72%), as reported by CARE (April 2, 2026). CARE reports that the business has raised about ₹1,399 crore from private equity investors over the years. Investors do not own the NCDs through this, but a history of fresh equity matters because it gives the lender a cushion when losses occur. In June 2026, ICRA expected a further ₹200 crore of equity, which the promoter had put into Vivriti Next Limited, to reach VCL in the quarter ended June 2026; until then the amount was placed with VCL as subordinated debt. Crisil's September 24, 2026 report still describes this ₹200 crore as extended to VCL as subordinated debt, and says the amount and timing of a further equity raise remain a monitorable. [CONFIRM] Crisil's report also gives the ultimate shareholding through Vivriti Next Limited: Creation Investments 56.2%, Lightrock 12.9% (plus 1.9% through LR India Fund I), Galina Private Equity Investments 11%, Vineet Sukumar 7.4%, Gaurav Kumar 7.3% and TVS Shriram Growth Fund 3.3%.
Vivriti Capital NCDs (Formerly Hari & Co.): Key Details
An NCD is a debt instrument. You lend money to the issuer, receive interest as per the terms of the issue, and get your principal back at maturity. Unlike a convertible debenture, a non-convertible debenture cannot be converted into shares.
Important: The three amounts are reported separately by three agencies and cover different sets of debentures. They should not be added together or interpreted as the size of a single public issue. These reports also do not establish whether any particular NCD is currently open for subscription by retail investors. The CARE rating letter uses the company's former name, Hari & Company Investments Madras Private Limited. The company was subsequently renamed Vivriti Capital Limited. Crisil has also rated a separate ₹200 crore NCD issue with a partial guarantee and a debt service reserve account at Crisil AA+ (CE)/Stable (April 10, 2026);[4] that rating applies only to that credit-enhanced issue, not to the company's other NCDs.
What the rating means: On the rating scales used by ICRA, CARE and Crisil, instruments rated 'A' are considered to offer an adequate degree of safety regarding timely servicing of financial obligations, and the '+' sign shows a relatively higher standing within that category. A Stable outlook means the agency does not expect the rating to change in the near term, while Crisil's Positive outlook reflects its expectation of sustained improvement in overall profitability. A credit rating is an opinion of the rating agency, not a recommendation to buy, sell or hold any security, and can be revised, suspended or withdrawn at any time. Check the latest rating on the rating agency's website before investing. The Credit risk-o-meter is based on evaluation of the credit risk of the issuer and does not constitute investment advice or a recommendation to invest. Investments in debt securities are also subject to market and liquidity risks.
ICRA's other rated amounts
The June 2026 report also rates ₹2,600 crore of long-term bank facilities at [ICRA]A+ (Stable). The ₹200 crore of new NCD capacity is shown as unutilised, which means it is rating room and not money already raised.
A third rating from Crisil
Crisil Ratings also assigned a Crisil A+/Stable (long term) and Crisil A1+ (short term) rating to the bank facilities and debt instruments transferred from the earlier Vivriti Capital to the company, in rating rationales dated April 10, 2026. Crisil later revised the outlook to Positive on July 16, 2026, citing its expectation of sustained improvement in overall profitability, and reaffirmed Crisil A+/Positive and Crisil A1+ on September 24, 2026. In its April 10, 2026 rationale, Crisil separately gave a Crisil AA+ (CE)/Stable rating to a ₹200 crore NCD issue that carries a partial guarantee and a debt service reserve account (DSRA). Crisil said that without those structural features, the NCD would have carried the same rating as the issuer. The lesson: a credit-enhanced issue can be rated higher than the company itself, so always check which instrument a rating belongs to.
Existing rated NCDs (as reported by the agencies)
The rating reports list the individual debentures below. They were issued by the earlier Vivriti Capital and transferred to the company, and the reports noted that re-listing under the new entity was under way. The status column shows the position as of November 13, 2026.
| Particular | ICRA | CARE Ratings | Crisil Ratings |
|---|---|---|---|
| Issuer | Vivriti Capital Limited (earlier Hari & Company Investments Madras Private Limited) | Hari & Company Investments Madras Private Limited (now Vivriti Capital Limited) | Vivriti Capital Limited |
| Instrument | Non-Convertible Debentures | Non-Convertible Debentures | Non-Convertible Debentures |
| NCD rating | [ICRA]A+ (Stable) | CARE A+; Stable | Crisil A+/Positive |
| Rated amount | ₹608 crore (₹408 crore reaffirmed, ₹200 crore newly assigned) | ₹1,150 crore | ₹1,050 crore |
| Rating action | Assigned in April 2026 and reaffirmed in June 2026 | Assigned in April 2026; no later CARE rating action identified as of November 16, 2026 | Assigned in April 2026; outlook revised to Positive on July 16, 2026; reaffirmed on September 24, 2026 |
| Report date | June 23, 2026 (earlier report dated April 13, 2026) | April 17, 2026 (rating letter) | September 24, 2026 |
Listed in the ICRA report (June 23, 2026):
| ISIN | Issue date | Coupon (per annum) | Maturity | Amount (₹ crore) | Status |
|---|---|---|---|---|---|
| INE01HV07379 | Apr 4, 2023 | 10.15% p.a. | May 25, 2026 | 25 | Matured and repaid in full; ICRA withdrew its rating |
| INE01HV07510 | Dec 24, 2024 | 9.74% p.a. | Jun 24, 2026 | 75 | Maturity date (Jun 24, 2026) has passed; confirm redemption from the company's disclosures |
| INE01HV07494 | Sep 27, 2024 | 10.6632% p.a. | Sep 27, 2026 | 100 | Maturity date (Sep 27, 2026) has passed; confirm redemption from the company's disclosures |
| INE01HV07528 | Dec 24, 2024 | 10.11% p.a. | Dec 23, 2026 | 225 | Not yet due; matures Dec 23, 2026 |
Listed in CARE's reports (April 2 and April 17, 2026; ₹1,150 crore in total):
| ISIN | Issue date | Coupon (per annum) | Maturity | Amount (₹ crore) | Status (as of Nov 13, 2026) |
|---|---|---|---|---|---|
| INE01HV07551 | Jun 5, 2025 | 9.86% p.a. | Jan 6, 2027 | 100 | Not yet due |
| INE01HV07569 | Jun 24, 2025 | 9.65% p.a. | Feb 5, 2028 | 75 | Not yet due |
| INE01HV07577 | Jun 24, 2025 | 9.30% p.a. | Jun 5, 2028 | 75 | Not yet due |
| INE01HV07593 | Jul 4, 2025 | 10.00% p.a. | Jul 4, 2028 | 100 | Not yet due |
| INE01HV07585 | Jun 30, 2025 | 10.10% p.a. | Oct 30, 2026 | 125 | Maturity date (Oct 30, 2026) has passed; confirm redemption |
| INE01HV07601 | Aug 19, 2025 | 10.10% p.a. | Aug 19, 2027 | 175 | Not yet due |
| INE01HV07635 | Sep 4, 2025 | 9.25% p.a. | May 4, 2028 | 150 | Not yet due |
| INE01HV07627 | Sep 4, 2025 | 9.15% p.a. | Nov 4, 2027 | 200 | Not yet due |
| INE01HV07619 | Sep 4, 2025 | 9.00% p.a. | Nov 4, 2026 | 150 | Maturity date (Nov 4, 2026) has passed; confirm redemption |
What Are Non-Convertible Debentures (NCDs)?
An NCD is a loan from you to a company, recorded as a debenture. You get interest at a rate fixed in the issue terms and your principal back at maturity. "Non-convertible" means the debenture can never be turned into shares, so if you hold it to maturity, your return comes only from interest and repayment.
How the interest can be paid
• Monthly, quarterly or annual payout (non-cumulative): you receive interest at regular intervals.
• Cumulative: interest builds up and is paid together with the principal at maturity.
The issue terms decide the frequency.
How the principal can be repaid
• Bullet: the full principal is repaid on the maturity date.
• Amortising: the principal is repaid in instalments, for example monthly, along with interest.
Crisil's note on the credit-enhanced issue mentioned above describes a monthly amortising structure, which shows how much the repayment pattern can differ between issues.
Secured or unsecured?
Secured NCDs are backed by specified assets or receivables. Unsecured NCDs depend on the issuer's general ability to pay. Never assume that all NCDs of one company carry the same security, maturity or repayment terms. The information memorandum or offer document is the only reliable source.
Listed or unlisted?
Listed NCDs can be sold on an exchange, but trading in many NCDs is thin, so you may not be able to sell quickly or at a fair price. Unlisted NCDs generally cannot be sold easily and are best treated as a hold-to-maturity commitment.
Understanding Vivriti Capital's Credit Rating
A credit rating is an independent opinion on how likely an issuer is to repay on time. Agencies look at the company's business, capital, asset quality, earnings, liquidity and funding.
The company's current ratings are:
• ICRA: [ICRA]A+ (Stable), assigned in April 2026 and reaffirmed on June 23, 2026
• CARE Ratings: CARE A+; Stable (April 17, 2026; no later action found as of November 13, 2026
• Crisil Ratings: Crisil A+ at issuer level, assigned on April 10, 2026; outlook revised to Positive on July 16, 2026, and Crisil A+/Positive reaffirmed on September 24, 2026; the short-term rating is Crisil A1+
What does A+ mean?
In India's rating scale, AAA denotes the highest degree of safety, AA a high degree of safety, and A an adequate degree of safety. BBB is moderate. So A+ sits in the upper part of the A category and is investment grade, but it is below AAA and AA. It reflects a lower credit risk than BBB or below, and a higher risk than AA or AAA.
A stable outlook means the agency expects the rating to hold over the next one to two years, if its assumptions about the company's performance prove right. Crisil's outlook is now Positive (July 16, 2026), which Crisil says is driven by its expectation of sustained improvement in overall profitability.
A rating is an opinion and not a guarantee. Rating agencies themselves state that ratings are not a recommendation to buy, sell or hold, and that they can be revised, upgraded, downgraded or withdrawn. [Insert Credit Risk-o-Meter for the rated instruments, with the rating agency's name and the rating in text below it, per SEBI circular HO/17/11/22(1)2026-DDHS-POD1 dated 7 Oct 2026.] The Credit risk-o-meter is based on evaluation of the credit risk of the issuer and does not constitute investment advice or a recommendation to invest. Investments in debt securities are also subject to market and liquidity risks.
Why did the agencies assign A+?
The positives they highlighted:
• Adequate capital: the capital adequacy ratio has stayed above 20% against a regulatory minimum of 15%. Managed gearing was 4.1 times at March 2026 and 4.2 times pro forma after the restructuring, and ICRA (June 2026) expected ₹200 crore of fresh equity.
• Experienced management and institutional backing: promoters with a long history in financial services and board-level involvement from private equity investors.
• Diversified funding: more than 70 lenders, with banks providing about half of borrowings.
• Scale-up of the business: AUM rose from ₹9,302 crore in March 2025 to ₹11,851 crore in March 2026.
• Stable earnings and adequate liquidity: returns on managed assets held at 2.2% in FY2026, and cumulative asset-liability mismatches were positive in every time bucket.
• Lower concentration: the top 20 exposures fell to 10% of AUM in March 2026 from 12% a year earlier and 15% in March 2023.
• Effective recoveries: Crisil pointed to the company's ability to recover from stressed enterprise accounts, which keeps final credit losses limited.
The constraints they highlighted: a limited track record, a loan book that is still maturing, rising bad loans, a large unsecured share, borrower concentration in weaker-rated entities, and credit costs that need to be controlled.
Financial Performance of Vivriti Capital
An NBFC repays its debt from the interest and principal it collects from borrowers, so the quality of its loan book, its profits and its capital are what matter. The figures below relate to the NBFC business of the earlier Vivriti Capital Limited, which now sits within the company. They are audited figures reported by ICRA.
| Metric (₹ crore unless stated) | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
| Total income | 1,051 | 1,364 | 1,665 |
| Profit after tax | 191 | 220 | 264 |
| Total managed assets | 9,521 | 10,868 | 13,162 |
| Return on managed assets | 2.3% | 2.2% | 2.2% |
| Managed gearing | 3.8x | 3.8x | 4.1x |
| Gross Stage 3 | 1.1% | 1.9% | 2.2% |
| Capital adequacy ratio | 21.3% | 21.0% | 21.0% |
Latest available data: Crisil's September 24, 2026 report gives the following for the quarter ended June 30, 2026 (Q1 FY2027): AUM of ₹11,395 crore, profit after tax of ₹73 crore, gross Stage 3 of 2.2%, net Stage 3 of 1.2%, capital adequacy of 22.5%, gearing of 3.6 times and net worth of ₹2,484 crore.
Growth in AUM
AUM was ₹5,836 crore in March 2023, ₹8,071 crore in March 2024, ₹9,302 crore in March 2025 and ₹11,851 crore in March 2026. ICRA and Crisil report a five-year compound annual growth rate of about 44% in AUM up to March 2026, a period that starts in March 2021. Over the last three years, from ₹5,836 crore in March 2023 to ₹11,851 crore in March 2026, AUM grew about 27% a year. Growth slowed to 15% in FY2025 before rising to 27% in FY2026, as credit growth in the NBFC sector cooled and unsecured loans came under pressure. The company aims for 20% to 25% annual growth over the next three years, with more lending to non-financial companies.
Profitability
Total income rose about 22% in FY2026 to ₹1,665 crore, and profit after tax rose about 20% to ₹264 crore. Return on managed assets was 1.9% in the first nine months of FY2026 and recovered to 2.2% for the full year, because some provisions were released in the March 2026 quarter after the RBI clarified the rules for loans covered by default loss guarantees. That one-off help matters: ICRA says the company will need to control credit costs and improve margins as its cost of funds is expected to rise. For earlier context, CARE reported a net interest margin of 5.84% and an average yield on advances of 15.15% for FY2025.
Capital and gearing
Capital adequacy was 21.0% in March 2026, against the 15% minimum. Managed gearing was 4.1 times, and ICRA put it at 4.2 times pro forma on April 1, 2026 after the restructuring. Crisil reports capital adequacy of 22.5% and gearing of 3.6 times as of June 30, 2026. Adjusted for exposure to group companies it is 4.4 times. ICRA says the ₹200 crore equity infusion is crucial to keeping gearing below 4.5 times as the book grows, and that the company is expected to support its sister asset management company up to 10% of its net worth if needed.
Liquidity
As of March 2026, the company held ₹350 crore of free cash and liquid investments and ₹50 crore of undrawn bank lines (ICRA, June 23, 2026). For April to September 2026, ICRA estimated scheduled collections averaging about ₹1,589 crore a month against debt repayments of ₹3,142 crore falling due in that period, and reported a liquidity coverage ratio of 115% as of March 2026. Asset-liability mismatches were positive in every bucket. More recently, Crisil reported cash and cash equivalents of ₹953 crore (including ₹165 crore of unutilised cash credit and working capital lines) and undrawn sanctions of ₹100 crore as of September 5, 2026, covering debt obligations due over the following month about 1.4 times, and no negative cumulative asset-liability gap up to one year as of June 30, 2026. ICRA rated liquidity adequate, and CARE adds that 90% to 95% of loans repay monthly, so cash comes in evenly through the year.
How the Loan Book and Funding Look
Where the money is lent
The two agencies cut the portfolio differently and at different dates, so treat these as two views of the same business and not as a single table.
• ICRA (March 2026): financial-sector entities about 32%, co-lending and partnerships about 32%, non-financial enterprises about 24%, and supply chain finance, leasing and factoring about 10%.
• CARE (December 2025): term loans and working capital loans 48%, co-lending 32%, direct assignment 7%, supply chain finance 4% and other products 9%.
Non-financial enterprise lending, including supply chain finance, made up 34% of AUM in March 2026, up from 28% a year earlier. The company wants to raise it to around 50% over the medium term, which will make the quality of that segment more important over time.
Who it lends to
Wholesale borrowers are mostly small and mid-sized NBFCs and companies with moderate risk profiles. ICRA reports that about 30% of exposures were in the BBB rating category and about 20% of AUM was to entities rated below investment grade or unrated, up from about 16% a year earlier. CARE (December 2025) puts BBB-and-below at 54% of wholesale exposure and unrated at 26%, and notes internal caps of ₹70 crore per entity and ₹105 crore per group. Most loans have an original tenor under three years and repay monthly, although longer-tenor loans have grown over time.
How it is funded
As of March 2026, ICRA reports more than 70 lenders, with banks providing about 50% of borrowings and NBFCs and financial institutions about 24%. The rest comes from private wealth managers, mutual funds, corporates and foreign investors. For the mix by instrument, CARE reported in December 2025 that borrowings comprised term loans (49%), bonds and NCDs (25%), working capital lines (7%), commercial paper (5%), foreign-currency borrowings (9%) and others (4%). CARE also reported that the average cost of funds rose to 9.92% in the first nine months of FY2026 from 9.30% in FY2025 and 8.94% in FY2024.
How Does Vivriti Capital Use NCDs?
NCDs are one of several tools the company uses to fund its loan book. The simple cycle looks like this:
1. The NBFC raises money through NCDs, bank loans, commercial paper and other borrowings.
2. It lends that money to enterprises, through supply chain finance and through co-lending partnerships.
3. Borrowers repay principal and interest on their schedules.
4. The NBFC uses those collections to pay its costs, interest and debt repayments, including to NCD holders.
The difference between what it earns on loans and what it pays on borrowings drives profit. Your repayment as an NCD holder depends on the whole company's cash flows and balance sheet, not on any one loan or product, unless the NCD is specifically secured against identified assets.
Key Risks of Investing in Vivriti Capital NCDs
Ratings of A+/Stable still leave real risks. The main ones are below.
1. Credit risk
The company can only repay you if its borrowers repay it. Defaults raise credit costs, reduce profit and can eventually affect its ability to pay lenders.
2. Asset quality
Gross Stage 3 loans rose from 1.1% in March 2024 to 1.9% in March 2025 and 2.2% in March 2026 (2.4% in December 2025). ICRA says a large part of this comes from a change in how co-lending delinquencies are reported under the revised digital lending guidelines, and that the losses are largely covered by partner guarantees and higher yields. Provisions were 1.6% of on-book AUM in March 2026, down from 1.9%. ICRA lists a sustained rise in loans overdue by 90 days or more beyond 3% of AUM as a potential downgrade trigger. CARE adds that the loan book is unseasoned, so true loss levels are not yet fully visible.
3. Borrower and segment concentration
Enterprise lending is concentrated in weaker-rated small and mid-sized borrowers, and the company is growing in non-financial sectors where its experience is shorter. ICRA notes that about 20% of AUM is to non-investment-grade or unrated borrowers. Diversification helps, but it does not remove risk.
4. Unsecured lending
CARE notes that about 36% of AUM was unsecured as of December 2025, and about 29% of AUM was unsecured loans under co-lending. With no collateral, recovery after a default is harder, so underwriting and collection quality matter more.
5. Co-lending and partnership risk
Under co-lending, partners originate and service many of the loans. The company sets underwriting criteria but depends on partners for day-to-day servicing. ICRA reports that Gross Stage 3 in the co-lending book was 4.0% in March 2026, 4.3% in March 2025 and 1.5% in March 2024. Losses are partly absorbed by first-loss default guarantees from partners, which under the revised guidelines are limited, in some cases to 5% of disbursements. The company therefore needs well-diversified partners and the ability to step in and collect on its own.
6. Funding cost risk
Cost of funds rose to 9.92% in the first nine months of FY2026, and ICRA expects it to rise further. If the company cannot pass higher costs on to borrowers, its margin shrinks.
7. Liquidity risk
Both ICRA and CARE called liquidity adequate in their reports, but debt repayments are large: ICRA reported ₹3,142 crore falling due from April to September 2026, against ₹350 crore of free cash as of March 2026 and expected collections. Crisil reported cash and cash equivalents of ₹953 crore as of September 5, 2026. Any disruption to collections or to market access can quickly put pressure on liquidity.
8. Capital-raising and growth risk
The growth plan depends on raising more equity. ICRA (June 2026) said the ₹200 crore infusion is crucial to keeping gearing below 4.5 times, and Crisil (September 2026) says the amount and timing of further equity remain a monitorable. If capital comes late, gearing can rise above the levels agencies are comfortable with.
9. Limited track record
The lending business began in 2017 and its loan book was built over about nine years. It has seen only a few credit cycles. The restructuring and renaming are recent, and the renamed company does not yet have its own full-year audited results as a lender.
10. Restructuring and documentation risk
The name change means that rating letters, offer documents, platform pages and older articles show different names for the same issuer. Transfer and re-listing of NCDs under the new entity was under way at the time of the April 2026 reports. Always match the ISIN and the issuer name in the offer document to the rating letter you are relying on.
11. Regulatory and macro risk
RBI rules on provisioning, digital lending, co-lending and default guarantees have already changed the business's numbers once. ICRA also notes that disruption from the West Asia conflict could affect borrower cash flows and is being monitored.
12. Rating risk
Ratings are reviewed periodically, and a downgrade can lower the market price of an NCD and make it harder to sell.
What Could Improve or Weaken the Rating?
Could support an upgrade:
• Scaling up with greater product diversification while keeping asset quality stable (CARE)
• Sustained improvement in earnings, with return on total assets above 2.5% (CARE)
• A sustained improvement in earnings while growing and keeping delinquencies tight (ICRA)
Could lead to a downgrade:
• Loans overdue by 90 days or more rising beyond 3% of AUM and hurting earnings (ICRA)
• Managed gearing above 4.5 times (ICRA) or overall gearing above 4.25 times (CARE)
• Return on total assets falling below 1.50% (CARE)
• A weaker liquidity position (ICRA)
These are the agencies' stated sensitivities and not predictions.
NCDs vs Bonds: What Investors Should Know
Both are debt securities: the issuer borrows from you, pays interest and returns the principal. "Bond" is the broader word. NCDs are a type of debenture that cannot be converted to shares, and they are mostly issued by companies and financial institutions.
| Feature | NCDs | Bonds |
|---|---|---|
| Meaning | Debt instruments that cannot be converted into equity | Broader category of debt securities from governments and companies |
| Convertibility | Non-convertible | May be convertible or non-convertible |
| Issuers | Mainly companies and financial institutions | Governments, public sector entities and companies |
| Interest payout | Monthly, quarterly, annual or cumulative, as per issue terms | Usually periodic, depends on issue terms |
| Security | Secured or unsecured | Secured or unsecured |
| Early exit features | Depends on the issue; many have none, some have call or put options | Callable, puttable and bullet structures are common |
| Risk | Depends on the issuer's credit quality and security | Government securities carry very low credit risk; corporate bonds depend on the issuer |
A word of caution: do not assume that every bond is safer than every NCD, or that NCDs always pay more. Safety depends on the issuer, the rating, the security and the terms. Higher yields usually reflect higher risk, whatever the label.
How returns are taxed (in general)
Tax rules change, so check the current position or speak to a tax advisor. In broad terms, under the Income-tax Act, 2025 (in force from 1 April 2026):
• Interest on NCDs and corporate bonds is taxed as income at your slab rate. Under Section 393(1) of the Income-tax Act, 2025 (Table, Sl. No. 5(i)), tax is deducted at source (TDS) on such interest at 10% for resident investors with a valid PAN, where the interest exceeds ₹10,000 in a year. [CONFIRM with Tax]
• If a listed NCD is sold after 12 months, the gain is a long-term capital gain, taxed at 12.5% without indexation. If sold within 12 months, it is a short-term gain taxed at your slab rate.
• For cumulative NCDs, interest is generally taxable on an accrual or receipt basis, depending on the investor's method of accounting, and not necessarily all at maturity. [CONFIRM with Tax]
• Gains on unlisted debt instruments are generally taxed at slab rates.
Investor Checklist Before Buying a Vivriti Capital NCD
1. Check the issuer name and ISIN. Make sure the document you are reading refers to Vivriti Capital Limited, formerly Hari & Company Investments Madras, and the exact ISIN.
2. Check the rating of the exact issue. Ratings are assigned instrument by instrument. Look up the latest rating letter and rationale on the rating agency's website, and check for any later upgrade, downgrade or outlook change, especially from CARE, whose latest report we found dates from April 2026. Crisil revised its outlook to Positive in July 2026 and reaffirmed the rating in September 2026.
3. Understand the security. Find out whether the NCD is secured or unsecured and, if secured, what the security is and how it is created.
4. Compare coupon and yield. Coupon is the stated rate. Yield is what you actually earn at your purchase price. Compare it with the risk and tenor, and with safer options like bank FDs and government bonds.
5. Check the maturity date. Make sure your money is not needed before then.
6. Review the payout and repayment structure. Is interest monthly, quarterly, annual or cumulative? Is the principal bullet or amortising?
7. Check liquidity. Listing does not guarantee that you can sell. Look at trading volume and the gap between buy and sell prices.
8. Read the offer document. It sets out the coupon, security, covenants, call or put options, risk factors and who the trustee is.
9. Check regulation and complaint channels. Listed securities fall under SEBI. CARE's press release dated April 17, 2026 notes that, for instruments regulated by bodies other than SEBI, SEBI's grievance redressal and investor protection mechanisms are not available, so check which regulator covers the instrument you are buying.
10. Look at the latest financials. Review the issuer's most recent results for asset quality, profit, gearing and capital adequacy, not just the rating reports.
11. Consider concentration risk. Exposure to any one issuer is a risk factor to consider.
What Factors Matter When Evaluating a Vivriti Capital NCD?
On the positive side, the company has A+ ratings from three agencies (Stable outlooks from ICRA and CARE, and a Positive outlook from Crisil since July 2026), capital above the regulatory minimum, an experienced team, broad funding and a growing book, with FY2026 profit of ₹264 crore. On the other side, bad loans have risen, a large part of the book is unsecured, the company relies on co-lending partners and fresh capital, and the loan book is still young.
Whether an NCD suits you depends on your risk tolerance, time horizon, income needs and ability to bear a loss. An A+ rating signals an adequate degree of safety. It does not remove the chance of delay or default. Look at the specific issue, its security and terms, and not at the issuer's rating alone. If you are unsure, consult a SEBI-registered investment adviser.
Conclusion
Vivriti Capital Limited, formerly Hari & Company Investments Madras Private Limited, is an NBFC with a diversified lending business and a growing asset base. Its NCDs and other debt were rated A+ with a Stable outlook by ICRA, CARE Ratings and Crisil in April 2026, and ICRA reaffirmed that rating in June 2026. Crisil has since revised its outlook to Positive (July 2026) and reaffirmed the rating (September 2026). The agencies point to adequate capital, experienced management and diversified funding as strengths. Rising bad loans, unsecured lending, co-lending dependence and higher funding costs are the main risks to watch.
One way to evaluate any NCD is to look past the rating and read the actual terms: security, coupon, maturity, repayment structure and liquidity. Weigh the income you might earn against the loss you might face, and consider how much you can afford to have tied up or at risk.
Published By
BondScanner, a SEBI-registered Online Bond Platform Provider (OBPP). Links to BondScanner's platform and app listings are for educational and informational discovery purposes only.
Disclaimer
This blog is intended solely for educational and informational purposes. The instruments, issuer categories, yield ranges, and examples mentioned herein are illustrative and should not be construed as investment advice or recommendations. BondScanner is a SEBI-registered OBPP and does not provide personalized investment advice. Nothing in this article is a solicitation to buy or sell any security. Fixed and coupon returns described in this article do not constitute guaranteed or assured returns. Investments in debt securities are subject to market, credit, and default risks, including delay and/or default in payment. Investors must read all offer-related documents carefully before investing.
Sustvest Broking Pvt. Ltd. | SEBI Reg. No. INZ000320834
FAQs on Vivriti Capital / Hari & Co. Bonds
Recent Blogs

Bond Basics
Lendingkart Finance Bonds: NCD Structure, Ratings & Risks
A comprehensive investor guide to Lendingkart Finance Limited NCDs, evaluating the unsecured small-business lending model, Fullerton's support, AA- and A+ credit ratings, FY2026 losses, asset quality and risk parameters.

Vinayak Rawat
10 Nov 2026





